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The current need to find new advanced approaches to carry biologically active substances
(conventional organic drugs, peptides, proteins (such as antibodies), and nucleic acid-based drugs
(NABDs such as siRNA and miRNA)) in the body fluids, to realize targeted therapies and even
personalized ones, goes hand in hand with research on the performance of new materials to better
realize appropriate drug vectors [1].
Polymeric materials can be designed and manufactured to obtain delivery systems with
the appropriate characteristics in terms of drug release and performance [2]. For use in human
applications, the polymer must primarily be biocompatible and non-toxic, and then functionalizable
to give the appropriate structural and functional characteristics, such as to make it easily workable,
processed, and engineered to obtain the desired system, and to be applied in drug delivery and targeting
and/or in diagnosis of diseases.
The further possibility of decorating the surface of these polymeric systems (due to the characteristics
of the material that constitutes the matrix) with ligands capable of interacting specifically with membrane
receptors on cells represents a unique advantage for obtaining targeted drug release to a specific organ,
tissue, or cell type [3–7].
In this issue, some current examples of design and production of polymeric materials, as well as of
searching strategies to modify existing ones, for the making of innovative systems for drug delivery
and/or regenerative medicine are collected.
In particular, polymeric systems from nanoscale (micelles [8,9], nanoparticles [10,11]) to microscale
structures (microparticles [12,13]), and to macrodevices (hydrogels [14] and films [15]) were produced.
All the described systems were designed for the controlled and targeted release of conventional
or biological drugs, such as paclitaxel [10], or siRNA [11] in the treatment of diseases such
as cancer [8] and buccal and skin infections [15,16] by the systemic or local administration route [17].
The starting polymeric materials were chosen from hydrophilic polysaccharides [11,16] to hydrophobic
polyesters [9,14], obtaining blended materials or copolymers, which were used to obtain drug delivery
systems by using techniques such as microfluidics or hot punching [12,13].
Polymeric porous microparticles are currently emerging due to their potential for various applications,
such as floating drug delivery systems and inhaled formulations. Amoyav and coworkers described
the preparation of porous microspheres (MPs) starting from poly(lactic-co-glycolic) acid (PLGA)
and poly(d,l-lactide) (PLA), with varying sizes and morphologies, by a simple flow-focusing microfluidic
device [13].
Characterization of obtained systems to predict the in vivo fate is a fundamental aspect for
researchers. Abid and coworkers described the production of microdevices, starting from different
polyesters (i.e., poly-ε-caprolactone (PCL) and poly(lactic-co-glycolic acid) (PLGA)) by hot punching,
and their characterization in terms of mucoadhesion with an ex vivo retention model and degradation
studies in the presence of pancreatic enzymes [12].
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Genetic material represents the new therapeutic approach to managing diseases. Sardo and coworkers
described the production of redox-responsive siRNA-loaded systems for magnetofection [11]. In particular,
siRNA-loaded magnetoplexes were able to release siRNA in a redox-triggered manner due to intracellular
glutathione (GSH) mediated reduction of disulphide bridges formed during the crosslinking process.
In another paper, the characterization and optimization of PLA in in-situ forming hydrogels (that exhibited
a sol-to-gel transition between room and body temperatures), composed of PEI/DNA multi-layered
micelles, for local gene delivery systems was described [14]. The investigation of their degradation profiles
and chemical analysis indicated the faster acidic degradation and stepwise degradation process of these
micelle–hydrogel systems.
Temperature-responsive behavior, as well as the capability to respond to pH or a reducing
environment, is achieved for systems ranging from nano- to microdevices to control the release of drugs.
Zhang and coworkers described the realization of nanoparticles starting from a temperature-responsive
PEGylated polyaspartamide derivative, which were used to carry paclitaxel, showing suitable
characteristics that make it a promising drug delivery system [10]. In another paper, biodegradable
polymeric micelles based on a polyurethane–polyethylene glycol copolymer with disulfide bonds in
the main chain (PEG–PU(SS)–PEG) were produced [8]. These systems were able to enable quick release
of entrapped doxorubicin under intracellular reducing conditions. Zhai and coworkers described
the production of pH-sensitive doxorubicin prodrug (mPEG–PCL–Imi–DOX) forming micelles that were
responsive to the acidic tissular or intra-tumor microenvironment [9]. In particular, the macromolecular
prodrug was synthesized by chemical conjugation of doxorubicin to the polymer via acid-cleavable
imine bonds, and DOX release from the prodrug micelles was pH-responsive and able to be accelerated
with a decrease of pH.
Topical administration on the skin or buccal mucosa represents a valid alternative to increased
drug efficacy and reduced side effects related to systemic or oral administration of drugs.
Marto and coworkers described a new approach to treat superficial skin infections by topical application
of antibiotics, such as minocycline hydrochloride, formulated in a novel starch-based Pickering
emulsion [16]. Junmahasathien and coworkers described the realization of pectin films, loaded with
metronidazole, for the treatment of periodontal disease [15]. The preliminary results showed that
low methoxyl pectin film containing glycerin and metronidazole could be potentially considered
as a promising clinical tool for drug delivery via an intra-periodontal pocket to target an oral disease
that is associated with polymicrobial infection.
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